Glutaminyl based DPIV inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S423000, C548S200000, C548S531000

Reexamination Certificate

active

07060719

ABSTRACT:
The present invention provides compounds of the formula:wherein X=CH2or S or pharmaceutical acceptable salts thereof useful for treating conditions mediated by DPIV or DPIV-like enzymes, such as arthritis, obesity, immune and autoimmune disorders, allograft transplantation, cancer, neuronal disorders and dermal diseases.

REFERENCES:
patent: 6548481 (2003-04-01), Demuth et al.
patent: 6849622 (2005-02-01), Yasuda et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Glutaminyl based DPIV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glutaminyl based DPIV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutaminyl based DPIV inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3639026

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.